Viewing Study NCT03295227


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT03295227
Status: RECRUITING
Last Update Posted: 2025-08-01
First Post: 2017-09-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module